Skip to main content

Table 4 Comparison of comorbidity data between normal human liver and ALD cohort

From: Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease

  Normal human liver ( n = 17) ALD (cirrhosis) ( n = 10) Statistical significance
Hypertension (N, %) 4 (23.5%) 4 (40%) ns
Any hypertensive medication (N, %) 4 (23.5%) 0 (0%) P = 0.046
T2DM (N, %) 0 (0%) 0 (0%) ns
Diet treated 0 (0%) 0 (0%) ns
Cardiovascular disease (N, %) 2 (11.7%) 0 (0%) ns
Dyslipidemia treated with lipid lowering agents (N, %) 3 (17.6%) 0 (0%) ns
1 Med 3 (17.6%) 0 (0%) ns
>2 Meds 0 (0%) 0 (0%) ns